Martin Poncelet

Title: Martin Poncelet: Innovator in Hybridoma Technology

Introduction

Martin Poncelet is a notable inventor based in Louvain-la-Neuve, Belgium. He has made significant contributions to the field of immunology, particularly in the development of hybridoma technology. His work has implications for the production of monoclonal antibodies, which are essential in various medical applications.

Latest Patents

Poncelet holds a patent for a process for the production of a hybridoma and the antibody obtained therefrom, which is capable of recognizing more than one vitamin D metabolite. This invention specifically addresses the production of a monoclonal antibody or fragments that can recognize 25-hydroxyvitamin D and 25-hydroxyvitamin D. His innovative approach enhances the ability to detect and measure vitamin D levels in clinical settings.

Career Highlights

Throughout his career, Martin Poncelet has been associated with Diasource Immunoassays S.A., a company known for its expertise in immunoassay technology. His work at Diasource has allowed him to focus on advancing diagnostic tools that benefit healthcare professionals and patients alike.

Collaborations

Poncelet has collaborated with esteemed colleagues such as Michel Anciaux and Fabienne Mathieu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of immunology.

Conclusion

Martin Poncelet's contributions to hybridoma technology and monoclonal antibody production represent a significant advancement in medical diagnostics. His work continues to influence the field and improve healthcare outcomes.